 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval L1 a5 D' S; K. F' g$ u8 A( ^
2 `- `9 f+ C! M+ W! C# VEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.& q" \: o, a3 v8 t( C1 f: C5 r
7 M( B4 k$ x- x3 I- K4 U" ~
BY THE EDMONTON JOURNAL FEBRUARY 16, 20073 |* b' s- y! w m; L
8 b, E; e8 r7 b- h; E/ ] $ ^" }' f/ x ~! O- J9 f
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
9 d' n3 Y2 |8 X4 {/ k ?) ^. b2 J
* E1 t. }- g6 }# B. U- ~The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."( G+ {5 o ^9 b% H
; p! V M+ J2 n. ?. U. n' x. {' J. y
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.- \& U; C U$ z
% U% y, e. _! OIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.# }% p; h( y( O" `/ w1 }) @# l
( B: `8 G' e$ a; D
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million./ A1 X9 I6 b* c/ [( L
3 q0 X$ c( G, m7 R1 g/ |( v
"As a scientist, it's one of the highlights of my CAREER," Shan said.
3 x0 ^9 B; [, m: H3 ~$ K
' w9 k! p! F2 n9 A8 h9 F"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
6 t! v3 y3 V: l6 e% V8 K
6 J6 o; V5 K9 m0 O H' A+ D9 bIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.# u) i: t% y d0 ?
4 I l8 p3 b- I- w# x# N Q
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
+ _; n. ] ]9 X0 \6 s# n' ?4 {& g$ J/ ~* \0 Z- S# X; _
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.& h' M4 a. y2 d6 b9 R
2 g6 O* O5 ]( k7 `# y
2 w$ U: v) K( Q0 r: x" Fhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
& {" g) c+ e0 x# q- X
发表于 2015-2-28 19:45
